Noam VanderWalde

Wanted to highlight a key RCT fpresented by @efratdotan #ASCO24. The GIANT TRIAL - first older adult focused treatment trial in pancreas cancer It highlights the importance of GERIONC trials and several key principles of oncology

2/10 The NEO-RT trial can be opened through @SWOG @NRGonc @ALLIANCE_org @eaonc and is supported by our study champions. @ChrisCannMD @geriradonc

New article (Vol 193) Short course RT versus RCT for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment Eric François et al. doi.org/10.1016/j.rado… thegreenjournal.com/article/S0167-…

🚨🚨🚨 EXTEND Trial Oligometastatic PDAC Randomized SOC vs +/- oligometastasis directed radiotherapy (MDT) 🔥 Addition of MDT improves PFS: 10.3 vs. 2.5 months, HR 0.43, p=0.03 👏🏽👏🏽 @ebludmir and team!!! #GI24

Older adults with cancer are an increasing proportion of the cancer population and will become nearly 70% of all diagnoses in coming years #SIOG23 @geriradonc @SIOGorg

Thank you ⁦@KHigginsMD⁩ for an excellent discussion and pointing out age restrictions. #ASTRO23 #gerionc

Meta-analysis Tumor Treating Fields (TTF) 9 studies, 1430 pts GBM · Median OS 23mos w/TTF vs 17 mos w/o · Usage rate ≥75% associated ↑OS rdcu.be/dihp3

The new MUST READ paper for geriatric oncologist is here! Many thanks and congrats to all the Authors! @SIOGorg @YoungSIOG Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update ascopubs.org/doi/10.1200/JC…

.@reshmajagsi and colleagues from @swog find low rates of locoregional recurrence and questionable role of regional nodal irradiation for #breastcancer on landmark trial S1007. Omission of chemotherapy not independent indication regional nodal irradiation. ja.ma/44A051V

Be at the Heart of the #SIOG2023 Action! Book your Meliá Valencia hotel stay NOW to save money, stay in the venue hosting the SIOG Annual Conference, and receive more chances to network. #GeriOnc loom.ly/Y_PiiGU

Johns Hopkins Kimmel Cancer Center Podcasts: On Target with Dr Akila Viswanathan - Personalization of Cancer Care for Older Adults for Seminars in Radiation Oncology #gerionc #radonc hopkinskimmel.libsyn.com/on-target-with…

#GeriatricOncology is a strong field of interest for our Radiation Oncologist & Co-Director of Clinical Research, Dr. Noam VanderWalde. In this #podcast, he discusses the importance of personalization for older cancer patients alongside Dr Akila Viswanathan & Dr Ben Movsas!

The European Society for Radiotherapy and Oncology (ESTRO) issued the following statement regarding the PROSPECT clinical trial for patients with resectable rectal cancer: lnkd.in/eAKgFCru #radiotherapy #radiationoncology #radonc

40 years ago this was predicted. The field of GO was marginalized as a niche field. All oncologists are geriatric oncologists. We are mainstream oncology. #gerionc #asco #carg dailymail.co.uk/health/article…

Congrats to all of the OPRA investigators and @DrGarciaAguilar - 5-year data presented today by Floris Verheij @MSKCancerCenter ; LCRT --> FOLFOX: higher rates of organ preservation, lower rates of local regrowth AND no decrement in oncologic outcomes @ASCO; #ASCO23 @ASCRS_1

Excellent discussion of the #rectalcancer PROSPECT trial by Dr. Corrie Marijnen, MD, PhD #ASCO23 From a pt POV, we want our care team of #medonc, #radonc & surgeons to work with us to find a treatment strategy for maximal benefit with minimum side effects #CRCSM @OncoAlert

Congrats to the authors of the PROSPECT trial! A tremendous accomplishment. #ASCO23 Some thoughts:

@5_utr @ALLIANCE_org This is a great point. I don’t think it’s a “pure” take at de-intensification. Also, some may be suitable to surgery alone, eg. Upper T3N0 with no risk factors. Real key in my opinion is appropriate generalization of the data to the correct patients